Cardiovascular Drugs Study Notes

Blood Circulation: - Blood flows from the atria to the ventricles, facilitating the transportation of oxygen and nutrients throughout the body.
- Deoxygenated blood flows into the right atrium from the systemic circuit and is sent to the right ventricle, where it is pumped to the lungs for oxygenation. Once oxygenated, the blood returns to the left atrium and is pumped into the left ventricle, which sends oxygenated blood through the aorta to the systemic circulation.
- This cyclical process is crucial for maintaining homeostasis, delivering essential elements to tissues, removing waste products, and ensuring optimal organ function.
Cardiac Cycle: - Includes the conduction cycles, which are essential for understanding the heartbeat and the effects of cardiovascular drugs.
- The cycle is composed of systole (contraction phase) and diastole (relaxation phase), during which the heart effectively fills with blood and pumps it into the circulatory system. The sinoatrial (SA) node acts as the primary pacemaker, coordinating the contraction sequence throughout the heart muscle.

Factors affecting hemodynamics: - Various regulatory actions on both cardiovascular and vascular sides critically impact hemodynamic stability.
- Direct actions (e.g., neural and hormonal responses) and reflex actions (e.g., baroreceptor reflex) can influence heart rate and blood vessel diameter, directly affecting cardiac output and systemic vascular resistance (SVR).
- Understanding these factors is vital for anticipating the response to various cardiovascular drugs, which can modulate these mechanisms strongly.

MOA connects to drug indications, effects, and side effects:
- A thorough understanding of each drug's mechanism allows healthcare professionals to predict potential interactions, therapeutic effects, and adverse effects, leading to more informed decisions during treatment.
- For example, certain drugs may enhance vasodilation or inhibit the renin-angiotensin-aldosterone system, impacting blood pressure and fluid balance.

CCS (Chronic Coronary Syndrome): - This term replaces stable angina and encompasses patients experiencing chronic coronary artery disease that leads to exertion-related symptoms.
- If untreated, it may progress to ACS (Acute Coronary Syndrome), characterized by sudden and severe chest pain, possibly indicating a heart attack.
Angina: - A symptom of Coronary Artery Disease (CAD), characterized by chest pain due to reduced blood flow to the heart muscle.
- Angina can present as stable angina (predictable episodes) or unstable angina (unpredictable and more severe), requiring urgent medical attention.
CAD (Coronary Artery Disease): - Defined by the narrowing or blockage of coronary arteries due to atherosclerosis, which can lead to heart attacks and needs careful management and treatment strategies.
Syndromes like CCS and ACS indicate collections of symptoms and signs that represent underlying pathophysiological changes in cardiac function.

Calcium Channel Blockers (CCBs): - These drugs impact various types of calcium channels in the heart, skeletal muscle, and blood vessels, leading to several cardiovascular effects.
- They primarily work by inhibiting the influx of calcium ions during depolarization, thereby reducing systemic vascular resistance (SVR) and facilitating decreased myocardial contractility.
- Impact on blood pressure (BP): Larger diameter blood vessels require lower pressure for blood flow, thus lowering overall BP noticeably.
Vasodilation Effects: - Vasodilation occurs due to relaxation of vascular smooth muscle, which leads to decreased BP and decreased SVR.
- The body compensates for this by adjusting cardiac output through various mechanisms, including reflex tachycardia, where the increase in heart rate attempts to maintain adequate tissue perfusion.

CCBs are indicated in the management of certain types of strokes, such as hemorrhagic stroke, primarily due to their ability to dilate cerebral blood vessels and improve cerebral perfusion.
First-generation CCBs (Dihydropyridines) primarily reduce vascular resistance and blood pressure, making them effective in managing hypertension and angina symptoms.
Increased awareness of organ damage due to prolonged high BP emphasizes the need for timely and effective pharmacological interventions.

Nitrates function primarily through venous dilation, primarily lowering preload and subsequently affecting cardiac output.
- Examples include nitroglycerin, Isosorbide Mononitrate (ISMN), and Isosorbide Dinitrate (ISDN), which are frequently used to treat angina by reducing myocardial oxygen demand.
- Proper management of preload is crucial as it refers to the stretching of the heart due to returning blood which influences cardiac output significantly.

Patients can develop tolerance to nitrates, often leading to phenomena such as headaches or diminishing therapeutic effects.
- It is advised that patients take breaks from continuous nitrate use (known as nitrate-free intervals) to maintain efficacy and reduce side effects.
There is ongoing research into the long-term effects and potential carcinogenic risks associated with various blood pressure medications, necessitating continuous clinical vigilance and management review.

It is crucial not to lower BP too rapidly during hypertensive emergencies, as this can lead to complications such as hypoxia and subsequent organ damage.
- Patients with elevated BP require careful and gradual management strategies, as abrupt interventions can exacerbate the condition.
- Coronary steel: This phenomenon occurs when managing myocardial blood supply involves delicate balance to avoid complications associated with over-medication or abrupt changes in BP.
It is also essential to be aware of conditions such as minoxidil use in treatment, as certain medications interact in ways that can significantly influence BP management.

The primary goals are to improve oxygen supply to the heart while decreasing oxygen demand, ultimately leading to enhanced patient outcomes.
- Focus on managing symptoms, preventing the progression to more severe syndromes, and protecting vital organs from damage caused by high BP remains paramount in therapeutic strategies.